Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes.
about
Cysteinyl leukotrienes: multi-functional mediators in allergic rhinitisMontelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.Leukotrienes and airway inflammationApoptosis, airway inflammation and anti-asthma therapy: from immunobiology to clinical application.Pharmacotherapy challenges of Fontan-associated plastic bronchitis: a rare pediatric disease.Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apneaLeukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway.Gastroprotective effects of montelukast and Nigella sativa oil against corticosteroid-induced gastric damage: they are much more than antiasthmatic drugs.Enhanced cysteinyl-leukotriene type 1 receptor expression in T cells from house dust mite-allergic individuals following stimulation with Der p.Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.Role of cysteinyl leukotriene receptor-1 antagonists in treatment of experimentally induced mammary tumor: does montelukast modulate antitumor and immunosuppressant effects of doxorubicin?Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma.Expression of cysteinyl leukotriene receptor 1 and 2 (CysLTR1 and CysLTR2) in the lymphocytes of hyperplastic tonsils: comparison between allergic and nonallergic snoring children.The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma.
P2860
Q28219122-2F1AAF2A-102F-4FC5-851D-EAC44E66C5FAQ34118491-BE48F3D2-98AD-4ECF-A9CE-BC868675E7BCQ35106124-3F9558AB-0B0B-4DE4-9AFF-347884E7819FQ37052175-2AA4A10D-27DB-44F7-8C7C-3F2411E56BE5Q37179472-C3A2E402-9746-4217-9B3E-5AFC897CEE4AQ37277243-10E63D0A-24B8-46E3-AC4B-8FCE1E26D46DQ37549767-64A4BC1E-4EAC-455B-A2C8-61FA9910F40EQ39104480-35EECEB7-D991-4D77-8774-BF28215AD3D2Q39400991-932873A7-F4D8-4F26-BAED-BE1B936358B0Q39622870-DDBA10C5-CC5C-40B1-B0DC-E2D19E43F43EQ40162059-547CBEEF-0475-412E-B232-FAD573A473E9Q40394553-5A69DBB8-70DF-4817-B27A-6A68698658D9Q48297033-272DAFBB-5223-4B9A-9315-BD7534150E45Q51427065-33EF652F-5623-48A7-99C3-4849784B39BAQ51799899-9A722C59-0D55-4025-B17D-35B9A25AB9E1
P2860
Biological effects of montelukast, a cysteinyl-leukotriene receptor-antagonist, on T lymphocytes.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@en
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@nl
type
label
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@en
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@nl
prefLabel
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@en
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@nl
P2093
P2860
P1476
Biological effects of monteluk ...... -antagonist, on T lymphocytes.
@en
P2093
Piattoni S
Russano AM
Spinozzi F
de Benedictis D
de Benedictis FM
P2860
P304
P356
10.1111/J.1365-2222.2004.02119.X
P577
2004-12-01T00:00:00Z